CellOptic, an engineering startup company focused on applying holography to biomedical imaging. One Health Scientific supported the inventor CEO to prepare a phase IIb SBIR submission, secure a local grant award, and strategically plan and engage with thought leaders to secure partners in order to commercialize their development of Fresnel INCoherence Holography (FINCH) for super resolution microscopy. 

Based out of Highlands Ranch, CO, Felix Pets LLC is an R+D stage biotech company that is focused on making the first hypoallergenic cat through genetic engineering. We developed with the founding partners proprietary technology to successfully generate the first gene-knockout cat; prosecuted patent applications and developed sponsored research agreements with academic and commercial service providers. 

Based out of Frederick, MD, Janus Sciences LLC is a start up company focused on making patient specific stem cell through a novel and proprietary technology. One Health Scientific helped the founders and CEO design and conduct a validation study, establish a laboratory at FITCI, and engage with thought leaders as well as potential strategic partners in the field. 

A cutting edge gene editing company generating RNAi rodent models for discovery, based out of Brooklyn, NY. We  support the founder/CEO to evaluate new technologies and pursue grant opportunities to generate comparative models for human health with academic and pharmaceutical partners.  

Navastra LLC is based out of Washington, D.C., they are an early stage start-up company focused on binding developmental biological discoveries into reproducible and scalable methods of harnessing the potential of stem cells for regenerative medicine. We work with the founder and CSO to help develop cell-based neural and haptic assays and secure contracts, patents and grants. 

Based out of Wake Forest, NC, VBI is an educational company that is dedicated to supporting the scientific community adopt the 3R's in research, (reduction, refinement, replacement). We helped the CEO and CSO develop and execute operating agreements that provide rodent surgical models for Wake Forest Innovations Preclinical Translational Services; contracts to develop GLP protocols and facility inspection; and established a training center at WFI hosting onsite and online conferences and courses for the biomedical research community.